CinDome Pharma

CinDome Pharma, founded in Cincinnati, Ohio, focuses on providing treatment for chronic gastroparesis, a debilitating gastrointestinal disorder. The company's mission is to improve the quality of life for millions affected by this condition through innovative medical solutions. CinDome Pharma is working on developing safer and more effective treatments than the currently available options, which include metoclopramide and domperidone, both of which have significant side effects and limitations.

Notable figures associated with CinDome Pharma include Dr. Brad Kuo from Massachusetts General Hospital. The company has made significant strides in addressing the unmet medical needs in gastroparesis treatment, aiming to offer safer alternatives to existing medications that carry severe risks like tardive dyskinesia and cardiovascular issues. CinDome Pharma's impact lies in its potential to revolutionize gastroparesis treatment, providing hope and improved health outcomes for patients worldwide.